search
Back to results

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19 (NextCOVE)

Primary Purpose

COVID-19

Status
Active
Phase
Phase 3
Locations
International
Study Type
Interventional
Intervention
mRNA-1283.222
mRNA-1273.222
Sponsored by
ModernaTX, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for COVID-19 focused on measuring mRNA-1283.222, mRNA-1273.222, SARS-CoV-2, SARS-CoV-2 Vaccine, Coronavirus, Virus Diseases, Messenger RNA, COVID-19, COVID-19 Vaccine, Moderna

Eligibility Criteria

12 Years - undefined (Child, Adult, Older Adult)All SexesAccepts Healthy Volunteers

Key Inclusion Criteria: Investigator's assessment that the participant understands and is willing and physically able to comply with protocol-mandated follow-up, including all procedures. For female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection, and agreement to continue adequate contraception or abstinence through 90 days following the vaccine administration. Has previously received a primary series of an authorized/approved COVID-19 vaccine. For participants ≥18 years of age, at least 1 booster dose must have also been received. Proof of prior vaccination is required. A heterologous vaccine regimen is acceptable. Key Exclusion Criteria: Has had close contact, as defined by the Centers for Disease Control and Prevention (CDC), with someone who had a SARS-CoV-2 infection in the past 14 days, or COVID-19 in the past 10 days. Participant is acutely ill or febrile (temperature ≥38.0 degree Celsius [°C]/100.4 degree Fahrenheit [°F]) 72 hours prior to or at the Screening Visit or Day 1. Any medical, psychiatric, or occupational condition, including reported history of substance abuse, that, in the opinion of the investigator, might pose additional risk due to participation in the study or could interfere with the interpretation of study results. Has received systemic immunosuppressants or immune-modifying drugs for >14 days in total within 181 days prior to Screening (for corticosteroids ≥10 mg/day of prednisone equivalent) or is anticipating the need for immunosuppressive treatment at any time during participation in the study. Has received or plans to receive any licensed vaccine ≤60 days prior to the study injection (Day 1) or plans to receive a licensed vaccine within 60 days after the study injection. Has received systemic immunoglobulins or blood products within 90 days prior to the Screening Visit or plans to receive during the study. Has donated ≥450 milliliters (mL) of blood products within 28 days prior to the Screening Visit or plans to donate blood products during the study. Has participated in an interventional clinical study within 28 days prior to the Screening Visit based on the medical history interview or plans to do so while participating in this study. Note: Other inclusion and exclusion criteria may apply.

Sites / Locations

  • Optimal Research
  • Accel Research Sites- Achieve Clinical Research
  • Chandler Clinical Trials
  • Phoenix Clinical Research LLC
  • FRC - CCT Research
  • Headlands Research Sarasota
  • Clinical Research Consortium
  • Noble Clinical Research, LLC
  • Del Sol research Management LLC.
  • Lynn Institute of the Ozarks
  • Anaheim Clinical Trials, LLC
  • Velocity Clinical Research, Banning
  • Velocity Clinical Research- Chula Vista
  • Benchmark Research
  • Marvel Clinical Research 002, LLC
  • Velocity Clinical Research Huntington Park
  • Velocity Clinical Research
  • Chemidox Clinical Trials
  • Long Beach Clinical Trials
  • Velocity Clinical Research- Westlake
  • Velocity Clinical Research-North Hollywood
  • Empire Clinical Research
  • CenExel - CITrials
  • Artemis Institute for Clinical Research
  • Peninsula Research Associates
  • Benchmark Research
  • Artemis Institute for Clinical Research
  • Acclaim Clinical Research
  • Lynn Institute of Denver
  • Velocity Clinical Research Denver
  • Tekton Research - Fort Collins
  • Tekton Research, Inc- Longmont Center
  • Alliance for Multispeciality Research - Miami
  • Nature Coast Clinical Research
  • Beautiful Minds Clinical Research Center
  • Clinical Research Partners LLC
  • Hillcrest Medical Research, LLC
  • Velocity Clinical Research, Hallandale Beach
  • Sweet Hope Research Specialty, Inc.
  • CenExel Research Centers of America
  • Nature Coast Clinical Research
  • Encore Research Group-Jacksonville Center for Clinical Research
  • Clinical Neuroscience Solutions, Inc
  • Health Awareness INC
  • Accel Clinical Research
  • Accel Research Sites
  • Acclaim Clinical Research
  • Floridian Clinical Research
  • Global Health Research Center, Inc.
  • Suncoast Research Group, LLC
  • Clinical Trials of Florida
  • Suncoast Research Associates, LLC
  • Clinical Neuroscience Solutions (CNS Healthcare site)
  • Headlands Research Orlando
  • Innovation Medical Research Center
  • Pines Care Research Center, Inc.
  • Suncoast Research Associates, LLC
  • Synexus
  • Precision Clinical Research
  • Global Health Research Center, Inc.
  • Santos Research Center CORP
  • Palm Beach Research Center
  • Delricht Research
  • Atlanta Clinical Research Center
  • Baybol Research Institute
  • Centricity Research
  • Elite Research Network
  • Accel Research Sites Lake Oconee
  • Georgia Clinic, PC/CCT Research
  • Clinical Research Atlanta/Headlands
  • Velocity Clinical Research
  • Chicago Clinical Research Institute
  • Great Lakes Clinical Trials
  • Velocity Clinical Research Valparaiso
  • Alliance for Multispecialty Research, LLC
  • Johnson County Clin-Trials, Inc (JCCT)
  • Alliance for Multispecialty Research, LLC- Wichita
  • Tekton Research Inc
  • Alliance for Multispecialty Research-Lexington
  • Versailles Family Medicine
  • Meridian Clinical Research
  • Benchmark Research
  • MedPharmics
  • Benchmark Research
  • Delricht Research
  • Delricht Clinical Research
  • Centennial Medical Group
  • Brigham and Women's Hospital
  • DM Clinical Research
  • Great Lakes Research Institute
  • Clinical Research Institute
  • Delricht Research
  • The Center for Pharmaceutical Research
  • Sundance Clinical Research, LLC
  • Delricht Research
  • Delricht Research
  • Montana Medical Research, Inc
  • CCT research/ Methodist Physicians Clinic- Prairie Fields
  • Velocity Clinical Research
  • Meridian Clinical Research, LLC
  • Velocity Clinical Research
  • Papillon Research Centre
  • Wr-Crcn, Llc
  • Las Vegas Clinical Trials
  • IMA Clinical Research
  • Velocity Clinical Research- New Mexico
  • IMA Clinical Research
  • Velocity Clinical Research, Syracuse
  • IMA Clinical Research
  • Rochester Clinical Research, Inc.
  • Monroe Biomedical Research
  • Trial Management Associates, LLC
  • CTI Clinical Research Center
  • Velocity Clinical Research, Inc
  • Velocity Clinical Research
  • Velocity Clinical Research - Cincinnati
  • Velocity Clinical Research
  • Tekton Research- Edmond
  • Tekton Research Inc
  • Delricht Research
  • Tekton Research- Yukon
  • Velocity Clinical Research, Medford
  • Summit Research Headlands LLC
  • DM Clinical Research
  • Synexus Clinical Research US, Inc
  • Velocity Clinical Research-Anderson
  • Delricht Research
  • Velocity Clinical Research
  • Velocity Clinical Research, Greenville
  • Carolina Health Specialists
  • Coastal Carolina Research Center
  • Spartanburg Medical Research
  • Velocity Clinical Research- Spartanburg
  • Delricht Research
  • Clinical Research Associates, Inc.
  • Benchmark Research
  • Tekton Research Inc
  • Tekton Research - Beaumont
  • PanAmerican Clinical Research, LLC
  • Headlands Research Brownsville
  • Zenos Clinical Research
  • Ventavia Research Group
  • Benchmark Research
  • DM Clinical Research
  • DM Clinical Research
  • Ventavia Research Group
  • DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINE
  • Research Your Health
  • Be Well Clinical Studies
  • Clinical Trials of Texas, Inc.
  • Diagnostics Research Group
  • Tekton Research -San Antonio
  • DM Clinical Research
  • DM Clinical Research
  • Cope Family Medicine
  • Mountain View Ogden Clinic/CCT Research
  • JBR Clinical Research
  • J. Lewis Research, Inc. / Foothill Family Clinic South
  • Health Research of Hampton Roads, Inc.
  • Velocity Clinical Research
  • Clinical Research Partners, LLC
  • Hamilton Medical Research group
  • Milestone Research Inc.
  • Red Maple Trials Inc.
  • Winterberry Family Medicine
  • Medicor Research Inc.
  • Dr. Anil K. Gupta Medicine Professional Corporation
  • Centricity Research Toronto Manna Multispecialty
  • Intermed groupe santé
  • Centricity Research Pointe-Claire
  • Manna Research Inc.
  • Q&T Research Sherbrooke Inc.
  • Clinique spécialisée en allergie
  • Barnsley Hospital
  • Royal United Hospital Bath NHS Trust - Royal United Hospital
  • Layton Medical Centre
  • Dorset Clinical Research Centre (Bournemouth Hospital)
  • Bradford Teaching Hospitals NHS Foundation Trust - Bradford
  • Lakeside Healthcare
  • Rotherham Doncaster and South Humber NHS Foundation Trust
  • University of Dundee - NHS Tayside - Ninewells Hospital & Me
  • Western General Hospital
  • Royal Devon & Exeter Hospital
  • CPS Research
  • NHS Greater Glasgow & Clyde
  • Panthera Biopartners - Glasgow - multispeciality
  • Queen Elizabeth University Hospital
  • Gloucestershire Hospitals NHS Foundation Trust - Cheltenham
  • Velocity Clinical Research High Wycombe
  • University Hospitals of Leicester-Leicester Royal Hospital
  • Barts Health NHS Trust
  • Egin Research
  • Guys and St. Thomas NHS Foundation Trust
  • Hammersmith Medicines Research (HMR)
  • Panthera Biopartners - Enfield
  • Richford Gate Medical Practice
  • Royal Free London NHS Foundation Trust
  • St Georges Healthcare NHS Trust - University of London
  • Manchester University NHS Foundation Trust
  • Bioluminux Clinical Research
  • Newcastle University - Institute of Cellular Medicine (ICM)
  • Velocity Clinical Research
  • Accellacare North London
  • Nottingham University Hospitals NHS Trust - Queens Medical Centre (QMC) Campus
  • Stemax Consult Healthcare Services Ltd
  • Wansford and Kings Cliffe Practice
  • University Hospitals Plymouth NHS Trust
  • Southampton General Hospital - Portsmouth Research Hub
  • GST NHS Found
  • Panthera Biopartners Preston
  • Panthera Biopartners - Manchester - multispeciality
  • Warrington and Halton Teaching hospitals NHS Foundation Trust - Halton General Hospital
  • Panthera Biopartners - Sheffield - multispeciality
  • Royal Victoria Infirmary
  • Southampton University Hospital NHS Foundation Trust
  • Pier Health Group
  • Weymouth Research Hub
  • North Wales Clinical Research Centre

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

mRNA-1283.222

mRNA-1273.222

Arm Description

Participants will receive single intramuscular (IM) injection of mRNA-1283.222 on Day 1.

Participants will receive single IM injection of mRNA-1273.222 on Day 1.

Outcomes

Primary Outcome Measures

Geometric Mean Ratio (GMR) of Omicron BA.4/5 mRNA-1283.222 Over the Omicron BA.4/5 mRNA-1273.222 After the Booster Dose
Seroresponse Rate (SRR) Difference of Omicron BA.4/5 Between mRNA-1283.222 and mRNA-1273.222 After the Booster Dose
Seroresponse at the participant level is defined as an antibody value change from baseline below the lower limit of quantification (LLOQ) to ≥4 × LLOQ, or at least a 4-fold rise if baseline is ≥LLOQ and <4 × LLOQ, or at least a 2-fold rise if baseline is ≥4 × LLOQ.
GMR of the Ancestral SARS-CoV-2 D614G mRNA-1283.222 Over the Ancestral SARS-CoV-2 D614G mRNA-1273.222 After the Booster Dose
SRR Difference of Ancestral SARS-CoV-2 D641G Between mRNA-1283.222 and mRNA-1273.222 After the Booster Dose
Seroresponse at the participant level is defined as an antibody value change from baseline below the (LLOQ) to ≥4 × LLOQ, or at least a 4-fold rise if baseline is ≥LLOQ and <4 × LLOQ, or at least a 2-fold rise if baseline is ≥4 × LLOQ.
rVE of mRNA-1283.222 and mRNA-1273.222 to Prevent the First Event of COVID-19
The rVE is defined as the percent of reduction in the hazards of the first occurrence of COVID-19 (mRNA-1283.222 vs. mRNA-1273.222) starting 14 days after the booster dose.
Number of Participants with Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs)
Number of Participants with Unsolicited Adverse Events (AEs)
Number of Participants with Any Serious AEs (SAEs), Medically Attended AEs (MAAEs), AEs Leading to Withdrawal From Study, and AEs of Special Interest (AESIs)

Secondary Outcome Measures

Geometric Mean Titers (GMTs) of Omicron BA.4/5 and Ancestral SARS-CoV-2 D614G
SRR Against Omicron BA.4/5 and Ancestral SARS-CoV-2 D614G
Seroresponse at the participant level is defined as an antibody value change from baseline below the (LLOQ) to ≥4 × LLOQ, or at least a 4-fold rise if baseline is ≥LLOQ and <4 × LLOQ, or at least a 2-fold rise if baseline is ≥4 × LLOQ.
Number of Participants with a SARS-CoV-2 Infection (Symptomatic or Asymptomatic)

Full Information

First Posted
April 13, 2023
Last Updated
September 6, 2023
Sponsor
ModernaTX, Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05815498
Brief Title
A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19
Acronym
NextCOVE
Official Title
A Randomized, Observer-Blind, Active-Controlled Phase 3 Study to Investigate the Safety, Immunogenicity, and Relative Vaccine Efficacy of mRNA-1283.222 Administered as a Booster Dose Compared With mRNA-1273.222 in Participants Aged 12 Years and Older for the Prevention of COVID-19
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 28, 2023 (Actual)
Primary Completion Date
August 23, 2024 (Anticipated)
Study Completion Date
August 23, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ModernaTX, Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222 vaccine as well as its immunogenicity in comparison to the mRNA-1273.222 vaccine.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19
Keywords
mRNA-1283.222, mRNA-1273.222, SARS-CoV-2, SARS-CoV-2 Vaccine, Coronavirus, Virus Diseases, Messenger RNA, COVID-19, COVID-19 Vaccine, Moderna

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
11471 (Actual)

8. Arms, Groups, and Interventions

Arm Title
mRNA-1283.222
Arm Type
Experimental
Arm Description
Participants will receive single intramuscular (IM) injection of mRNA-1283.222 on Day 1.
Arm Title
mRNA-1273.222
Arm Type
Experimental
Arm Description
Participants will receive single IM injection of mRNA-1273.222 on Day 1.
Intervention Type
Biological
Intervention Name(s)
mRNA-1283.222
Intervention Description
Sterile liquid for injection
Intervention Type
Biological
Intervention Name(s)
mRNA-1273.222
Intervention Description
Sterile liquid for injection
Primary Outcome Measure Information:
Title
Geometric Mean Ratio (GMR) of Omicron BA.4/5 mRNA-1283.222 Over the Omicron BA.4/5 mRNA-1273.222 After the Booster Dose
Time Frame
Day 29
Title
Seroresponse Rate (SRR) Difference of Omicron BA.4/5 Between mRNA-1283.222 and mRNA-1273.222 After the Booster Dose
Description
Seroresponse at the participant level is defined as an antibody value change from baseline below the lower limit of quantification (LLOQ) to ≥4 × LLOQ, or at least a 4-fold rise if baseline is ≥LLOQ and <4 × LLOQ, or at least a 2-fold rise if baseline is ≥4 × LLOQ.
Time Frame
Day 29
Title
GMR of the Ancestral SARS-CoV-2 D614G mRNA-1283.222 Over the Ancestral SARS-CoV-2 D614G mRNA-1273.222 After the Booster Dose
Time Frame
Day 29
Title
SRR Difference of Ancestral SARS-CoV-2 D641G Between mRNA-1283.222 and mRNA-1273.222 After the Booster Dose
Description
Seroresponse at the participant level is defined as an antibody value change from baseline below the (LLOQ) to ≥4 × LLOQ, or at least a 4-fold rise if baseline is ≥LLOQ and <4 × LLOQ, or at least a 2-fold rise if baseline is ≥4 × LLOQ.
Time Frame
Day 29
Title
rVE of mRNA-1283.222 and mRNA-1273.222 to Prevent the First Event of COVID-19
Description
The rVE is defined as the percent of reduction in the hazards of the first occurrence of COVID-19 (mRNA-1283.222 vs. mRNA-1273.222) starting 14 days after the booster dose.
Time Frame
From 14 days after injection to Day 365
Title
Number of Participants with Solicited Local and Systemic Reactogenicity Adverse Reactions (ARs)
Time Frame
Up to Day 7 (7-day follow-up after vaccination)
Title
Number of Participants with Unsolicited Adverse Events (AEs)
Time Frame
Up to Day 28 (28-day follow-up after vaccination)
Title
Number of Participants with Any Serious AEs (SAEs), Medically Attended AEs (MAAEs), AEs Leading to Withdrawal From Study, and AEs of Special Interest (AESIs)
Time Frame
Day 1 to end of study (EOS) (Day 365)
Secondary Outcome Measure Information:
Title
Geometric Mean Titers (GMTs) of Omicron BA.4/5 and Ancestral SARS-CoV-2 D614G
Time Frame
Days 91, 181, and 365
Title
SRR Against Omicron BA.4/5 and Ancestral SARS-CoV-2 D614G
Description
Seroresponse at the participant level is defined as an antibody value change from baseline below the (LLOQ) to ≥4 × LLOQ, or at least a 4-fold rise if baseline is ≥LLOQ and <4 × LLOQ, or at least a 2-fold rise if baseline is ≥4 × LLOQ.
Time Frame
Days 29, 91, 181, and 365
Title
Number of Participants with a SARS-CoV-2 Infection (Symptomatic or Asymptomatic)
Time Frame
From 14 days after injection to Day 365

10. Eligibility

Sex
All
Minimum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Key Inclusion Criteria: Investigator's assessment that the participant understands and is willing and physically able to comply with protocol-mandated follow-up, including all procedures. For female participants of childbearing potential: negative pregnancy test, adequate contraception or has abstained from all activities that could result in pregnancy for at least 28 days prior to the first injection, and agreement to continue adequate contraception or abstinence through 90 days following the vaccine administration. Has previously received a primary series of an authorized/approved COVID-19 vaccine. For participants ≥18 years of age, at least 1 booster dose must have also been received. Proof of prior vaccination is required. A heterologous vaccine regimen is acceptable. Key Exclusion Criteria: Has had close contact, as defined by the Centers for Disease Control and Prevention (CDC), with someone who had a SARS-CoV-2 infection in the past 14 days, or COVID-19 in the past 10 days. Participant is acutely ill or febrile (temperature ≥38.0 degree Celsius [°C]/100.4 degree Fahrenheit [°F]) 72 hours prior to or at the Screening Visit or Day 1. Any medical, psychiatric, or occupational condition, including reported history of substance abuse, that, in the opinion of the investigator, might pose additional risk due to participation in the study or could interfere with the interpretation of study results. Has received systemic immunosuppressants or immune-modifying drugs for >14 days in total within 181 days prior to Screening (for corticosteroids ≥10 mg/day of prednisone equivalent) or is anticipating the need for immunosuppressive treatment at any time during participation in the study. Has received or plans to receive any licensed vaccine ≤60 days prior to the study injection (Day 1) or plans to receive a licensed vaccine within 60 days after the study injection. Has received systemic immunoglobulins or blood products within 90 days prior to the Screening Visit or plans to receive during the study. Has donated ≥450 milliliters (mL) of blood products within 28 days prior to the Screening Visit or plans to donate blood products during the study. Has participated in an interventional clinical study within 28 days prior to the Screening Visit based on the medical history interview or plans to do so while participating in this study. Note: Other inclusion and exclusion criteria may apply.
Facility Information:
Facility Name
Optimal Research
City
Huntsville
State/Province
Alabama
ZIP/Postal Code
35802
Country
United States
Facility Name
Accel Research Sites- Achieve Clinical Research
City
Vestavia Hills
State/Province
Alabama
ZIP/Postal Code
35216
Country
United States
Facility Name
Chandler Clinical Trials
City
Chandler
State/Province
Arizona
ZIP/Postal Code
85224
Country
United States
Facility Name
Phoenix Clinical Research LLC
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85014
Country
United States
Facility Name
FRC - CCT Research
City
Phoenix
State/Province
Arizona
ZIP/Postal Code
85244
Country
United States
Facility Name
Headlands Research Sarasota
City
Scottsdale
State/Province
Arizona
ZIP/Postal Code
85260
Country
United States
Facility Name
Clinical Research Consortium
City
Tempe
State/Province
Arizona
ZIP/Postal Code
85281
Country
United States
Facility Name
Noble Clinical Research, LLC
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85704
Country
United States
Facility Name
Del Sol research Management LLC.
City
Tucson
State/Province
Arizona
ZIP/Postal Code
85715
Country
United States
Facility Name
Lynn Institute of the Ozarks
City
Little Rock
State/Province
Arkansas
ZIP/Postal Code
72204
Country
United States
Facility Name
Anaheim Clinical Trials, LLC
City
Anaheim
State/Province
California
ZIP/Postal Code
92801
Country
United States
Facility Name
Velocity Clinical Research, Banning
City
Banning
State/Province
California
ZIP/Postal Code
92220
Country
United States
Facility Name
Velocity Clinical Research- Chula Vista
City
Chula Vista
State/Province
California
ZIP/Postal Code
91911
Country
United States
Facility Name
Benchmark Research
City
Colton
State/Province
California
ZIP/Postal Code
92324
Country
United States
Facility Name
Marvel Clinical Research 002, LLC
City
Huntington Beach
State/Province
California
ZIP/Postal Code
92647
Country
United States
Facility Name
Velocity Clinical Research Huntington Park
City
Huntington Park
State/Province
California
ZIP/Postal Code
90255
Country
United States
Facility Name
Velocity Clinical Research
City
La Mesa
State/Province
California
ZIP/Postal Code
91942
Country
United States
Facility Name
Chemidox Clinical Trials
City
Lancaster
State/Province
California
ZIP/Postal Code
93534
Country
United States
Facility Name
Long Beach Clinical Trials
City
Long Beach
State/Province
California
ZIP/Postal Code
90806
Country
United States
Facility Name
Velocity Clinical Research- Westlake
City
Los Angeles
State/Province
California
ZIP/Postal Code
90057
Country
United States
Facility Name
Velocity Clinical Research-North Hollywood
City
North Hollywood
State/Province
California
ZIP/Postal Code
90036
Country
United States
Facility Name
Empire Clinical Research
City
Pomona
State/Province
California
ZIP/Postal Code
91786
Country
United States
Facility Name
CenExel - CITrials
City
Riverside
State/Province
California
ZIP/Postal Code
82506
Country
United States
Facility Name
Artemis Institute for Clinical Research
City
Riverside
State/Province
California
ZIP/Postal Code
92503
Country
United States
Facility Name
Peninsula Research Associates
City
Rolling Hills Estates
State/Province
California
ZIP/Postal Code
90274
Country
United States
Facility Name
Benchmark Research
City
Sacramento
State/Province
California
ZIP/Postal Code
95864
Country
United States
Facility Name
Artemis Institute for Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92103
Country
United States
Facility Name
Acclaim Clinical Research
City
San Diego
State/Province
California
ZIP/Postal Code
92120
Country
United States
Facility Name
Lynn Institute of Denver
City
Aurora
State/Province
Colorado
ZIP/Postal Code
80012
Country
United States
Facility Name
Velocity Clinical Research Denver
City
Denver
State/Province
Colorado
ZIP/Postal Code
80209
Country
United States
Facility Name
Tekton Research - Fort Collins
City
Fort Collins
State/Province
Colorado
ZIP/Postal Code
80525
Country
United States
Facility Name
Tekton Research, Inc- Longmont Center
City
Longmont
State/Province
Colorado
ZIP/Postal Code
80501
Country
United States
Facility Name
Alliance for Multispeciality Research - Miami
City
Coral Gables
State/Province
Florida
ZIP/Postal Code
33134
Country
United States
Facility Name
Nature Coast Clinical Research
City
Crystal River
State/Province
Florida
ZIP/Postal Code
34429
Country
United States
Facility Name
Beautiful Minds Clinical Research Center
City
Cutler Bay
State/Province
Florida
ZIP/Postal Code
33157
Country
United States
Facility Name
Clinical Research Partners LLC
City
DeLand
State/Province
Florida
ZIP/Postal Code
32720
Country
United States
Facility Name
Hillcrest Medical Research, LLC
City
DeLand
State/Province
Florida
ZIP/Postal Code
32720
Country
United States
Facility Name
Velocity Clinical Research, Hallandale Beach
City
Hallandale Beach
State/Province
Florida
ZIP/Postal Code
33009
Country
United States
Facility Name
Sweet Hope Research Specialty, Inc.
City
Hialeah
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
CenExel Research Centers of America
City
Hollywood
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Facility Name
Nature Coast Clinical Research
City
Inverness
State/Province
Florida
ZIP/Postal Code
34452
Country
United States
Facility Name
Encore Research Group-Jacksonville Center for Clinical Research
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32216
Country
United States
Facility Name
Clinical Neuroscience Solutions, Inc
City
Jacksonville
State/Province
Florida
ZIP/Postal Code
32256
Country
United States
Facility Name
Health Awareness INC
City
Jupiter
State/Province
Florida
ZIP/Postal Code
33458
Country
United States
Facility Name
Accel Clinical Research
City
Lakeland
State/Province
Florida
ZIP/Postal Code
33803
Country
United States
Facility Name
Accel Research Sites
City
Largo
State/Province
Florida
ZIP/Postal Code
33709
Country
United States
Facility Name
Acclaim Clinical Research
City
Maitland
State/Province
Florida
ZIP/Postal Code
32751
Country
United States
Facility Name
Floridian Clinical Research
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Global Health Research Center, Inc.
City
Miami Lakes
State/Province
Florida
ZIP/Postal Code
33016
Country
United States
Facility Name
Suncoast Research Group, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33135
Country
United States
Facility Name
Clinical Trials of Florida
City
Miami
State/Province
Florida
ZIP/Postal Code
33186
Country
United States
Facility Name
Suncoast Research Associates, LLC
City
Miami
State/Province
Florida
ZIP/Postal Code
33713
Country
United States
Facility Name
Clinical Neuroscience Solutions (CNS Healthcare site)
City
Orlando
State/Province
Florida
ZIP/Postal Code
32801
Country
United States
Facility Name
Headlands Research Orlando
City
Orlando
State/Province
Florida
ZIP/Postal Code
32819
Country
United States
Facility Name
Innovation Medical Research Center
City
Palmetto Bay
State/Province
Florida
ZIP/Postal Code
33157
Country
United States
Facility Name
Pines Care Research Center, Inc.
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33024
Country
United States
Facility Name
Suncoast Research Associates, LLC
City
Pembroke Pines
State/Province
Florida
ZIP/Postal Code
33324
Country
United States
Facility Name
Synexus
City
Pinellas Park
State/Province
Florida
ZIP/Postal Code
33781
Country
United States
Facility Name
Precision Clinical Research
City
Sunrise
State/Province
Florida
ZIP/Postal Code
33351
Country
United States
Facility Name
Global Health Research Center, Inc.
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Facility Name
Santos Research Center CORP
City
Tampa
State/Province
Florida
ZIP/Postal Code
33615
Country
United States
Facility Name
Palm Beach Research Center
City
West Palm Beach
State/Province
Florida
ZIP/Postal Code
33409
Country
United States
Facility Name
Delricht Research
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30329
Country
United States
Facility Name
Atlanta Clinical Research Center
City
Atlanta
State/Province
Georgia
ZIP/Postal Code
30342
Country
United States
Facility Name
Baybol Research Institute
City
Chamblee
State/Province
Georgia
ZIP/Postal Code
30341
Country
United States
Facility Name
Centricity Research
City
Columbus
State/Province
Georgia
ZIP/Postal Code
31904
Country
United States
Facility Name
Elite Research Network
City
Decatur
State/Province
Georgia
ZIP/Postal Code
30030
Country
United States
Facility Name
Accel Research Sites Lake Oconee
City
Eatonton
State/Province
Georgia
ZIP/Postal Code
31024
Country
United States
Facility Name
Georgia Clinic, PC/CCT Research
City
Norcross
State/Province
Georgia
ZIP/Postal Code
30092
Country
United States
Facility Name
Clinical Research Atlanta/Headlands
City
Stockbridge
State/Province
Georgia
ZIP/Postal Code
30281
Country
United States
Facility Name
Velocity Clinical Research
City
Meridian
State/Province
Idaho
ZIP/Postal Code
83642
Country
United States
Facility Name
Chicago Clinical Research Institute
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60607
Country
United States
Facility Name
Great Lakes Clinical Trials
City
Chicago
State/Province
Illinois
ZIP/Postal Code
60640
Country
United States
Facility Name
Velocity Clinical Research Valparaiso
City
Valparaiso
State/Province
Indiana
ZIP/Postal Code
46383
Country
United States
Facility Name
Alliance for Multispecialty Research, LLC
City
El Dorado
State/Province
Kansas
ZIP/Postal Code
67042
Country
United States
Facility Name
Johnson County Clin-Trials, Inc (JCCT)
City
Lenexa
State/Province
Kansas
ZIP/Postal Code
66219
Country
United States
Facility Name
Alliance for Multispecialty Research, LLC- Wichita
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67207
Country
United States
Facility Name
Tekton Research Inc
City
Wichita
State/Province
Kansas
ZIP/Postal Code
67218
Country
United States
Facility Name
Alliance for Multispecialty Research-Lexington
City
Lexington
State/Province
Kentucky
ZIP/Postal Code
40509
Country
United States
Facility Name
Versailles Family Medicine
City
Versailles
State/Province
Kentucky
ZIP/Postal Code
40383
Country
United States
Facility Name
Meridian Clinical Research
City
Baton Rouge
State/Province
Louisiana
ZIP/Postal Code
70809
Country
United States
Facility Name
Benchmark Research
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
MedPharmics
City
Covington
State/Province
Louisiana
ZIP/Postal Code
70433
Country
United States
Facility Name
Benchmark Research
City
Metairie
State/Province
Louisiana
ZIP/Postal Code
70006
Country
United States
Facility Name
Delricht Research
City
New Orleans
State/Province
Louisiana
ZIP/Postal Code
70115
Country
United States
Facility Name
Delricht Clinical Research
City
Prairieville
State/Province
Louisiana
ZIP/Postal Code
70769
Country
United States
Facility Name
Centennial Medical Group
City
Eldridge
State/Province
Maryland
ZIP/Postal Code
21075
Country
United States
Facility Name
Brigham and Women's Hospital
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02115
Country
United States
Facility Name
DM Clinical Research
City
Brookline
State/Province
Massachusetts
ZIP/Postal Code
02445
Country
United States
Facility Name
Great Lakes Research Institute
City
Southfield
State/Province
Michigan
ZIP/Postal Code
48075
Country
United States
Facility Name
Clinical Research Institute
City
Minneapolis
State/Province
Minnesota
ZIP/Postal Code
55402
Country
United States
Facility Name
Delricht Research
City
Gulfport
State/Province
Mississippi
ZIP/Postal Code
39503
Country
United States
Facility Name
The Center for Pharmaceutical Research
City
Kansas City
State/Province
Missouri
ZIP/Postal Code
64114
Country
United States
Facility Name
Sundance Clinical Research, LLC
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63141
Country
United States
Facility Name
Delricht Research
City
Springfield
State/Province
Missouri
ZIP/Postal Code
65807
Country
United States
Facility Name
Delricht Research
City
Town And Country
State/Province
Missouri
ZIP/Postal Code
63017
Country
United States
Facility Name
Montana Medical Research, Inc
City
Missoula
State/Province
Montana
ZIP/Postal Code
59808
Country
United States
Facility Name
CCT research/ Methodist Physicians Clinic- Prairie Fields
City
Fremont
State/Province
Nebraska
ZIP/Postal Code
68025
Country
United States
Facility Name
Velocity Clinical Research
City
Grand Island
State/Province
Nebraska
ZIP/Postal Code
68803
Country
United States
Facility Name
Meridian Clinical Research, LLC
City
Lincoln
State/Province
Nebraska
ZIP/Postal Code
68510
Country
United States
Facility Name
Velocity Clinical Research
City
Omaha
State/Province
Nebraska
ZIP/Postal Code
68134
Country
United States
Facility Name
Papillon Research Centre
City
Papillion
State/Province
Nebraska
ZIP/Postal Code
68046
Country
United States
Facility Name
Wr-Crcn, Llc
City
Las Vegas
State/Province
Nevada
ZIP/Postal Code
89113
Country
United States
Facility Name
Las Vegas Clinical Trials
City
North Las Vegas
State/Province
Nevada
ZIP/Postal Code
89030
Country
United States
Facility Name
IMA Clinical Research
City
Warren
State/Province
New Jersey
ZIP/Postal Code
07059
Country
United States
Facility Name
Velocity Clinical Research- New Mexico
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87102
Country
United States
Facility Name
IMA Clinical Research
City
Albuquerque
State/Province
New Mexico
ZIP/Postal Code
87109
Country
United States
Facility Name
Velocity Clinical Research, Syracuse
City
East Syracuse
State/Province
New York
ZIP/Postal Code
13057
Country
United States
Facility Name
IMA Clinical Research
City
New York
State/Province
New York
ZIP/Postal Code
10036
Country
United States
Facility Name
Rochester Clinical Research, Inc.
City
Rochester
State/Province
New York
ZIP/Postal Code
14609
Country
United States
Facility Name
Monroe Biomedical Research
City
Monroe
State/Province
North Carolina
ZIP/Postal Code
28112
Country
United States
Facility Name
Trial Management Associates, LLC
City
Wilmington
State/Province
North Carolina
ZIP/Postal Code
28403
Country
United States
Facility Name
CTI Clinical Research Center
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45212
Country
United States
Facility Name
Velocity Clinical Research, Inc
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45219
Country
United States
Facility Name
Velocity Clinical Research
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45242
Country
United States
Facility Name
Velocity Clinical Research - Cincinnati
City
Cincinnati
State/Province
Ohio
ZIP/Postal Code
45246
Country
United States
Facility Name
Velocity Clinical Research
City
Cleveland
State/Province
Ohio
ZIP/Postal Code
44122
Country
United States
Facility Name
Tekton Research- Edmond
City
Edmond
State/Province
Oklahoma
ZIP/Postal Code
73013
Country
United States
Facility Name
Tekton Research Inc
City
Moore
State/Province
Oklahoma
ZIP/Postal Code
73160
Country
United States
Facility Name
Delricht Research
City
Tulsa
State/Province
Oklahoma
ZIP/Postal Code
74133
Country
United States
Facility Name
Tekton Research- Yukon
City
Yukon
State/Province
Oklahoma
ZIP/Postal Code
73099
Country
United States
Facility Name
Velocity Clinical Research, Medford
City
Medford
State/Province
Oregon
ZIP/Postal Code
97504
Country
United States
Facility Name
Summit Research Headlands LLC
City
Portland
State/Province
Oregon
ZIP/Postal Code
97210
Country
United States
Facility Name
DM Clinical Research
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19107
Country
United States
Facility Name
Synexus Clinical Research US, Inc
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
Facility Name
Velocity Clinical Research-Anderson
City
Anderson
State/Province
South Carolina
ZIP/Postal Code
29621
Country
United States
Facility Name
Delricht Research
City
Charleston
State/Province
South Carolina
ZIP/Postal Code
29407
Country
United States
Facility Name
Velocity Clinical Research
City
Columbia
State/Province
South Carolina
ZIP/Postal Code
29204
Country
United States
Facility Name
Velocity Clinical Research, Greenville
City
Greenville
State/Province
South Carolina
ZIP/Postal Code
29615
Country
United States
Facility Name
Carolina Health Specialists
City
Myrtle Beach
State/Province
South Carolina
ZIP/Postal Code
29572
Country
United States
Facility Name
Coastal Carolina Research Center
City
North Charleston
State/Province
South Carolina
ZIP/Postal Code
29464
Country
United States
Facility Name
Spartanburg Medical Research
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
Velocity Clinical Research- Spartanburg
City
Spartanburg
State/Province
South Carolina
ZIP/Postal Code
29303
Country
United States
Facility Name
Delricht Research
City
Hendersonville
State/Province
Tennessee
ZIP/Postal Code
37075
Country
United States
Facility Name
Clinical Research Associates, Inc.
City
Nashville
State/Province
Tennessee
ZIP/Postal Code
37203
Country
United States
Facility Name
Benchmark Research
City
Austin
State/Province
Texas
ZIP/Postal Code
78705
Country
United States
Facility Name
Tekton Research Inc
City
Austin
State/Province
Texas
ZIP/Postal Code
78745
Country
United States
Facility Name
Tekton Research - Beaumont
City
Beaumont
State/Province
Texas
ZIP/Postal Code
77706
Country
United States
Facility Name
PanAmerican Clinical Research, LLC
City
Brownsville
State/Province
Texas
ZIP/Postal Code
78520
Country
United States
Facility Name
Headlands Research Brownsville
City
Brownsville
State/Province
Texas
ZIP/Postal Code
78526
Country
United States
Facility Name
Zenos Clinical Research
City
Dallas
State/Province
Texas
ZIP/Postal Code
75230
Country
United States
Facility Name
Ventavia Research Group
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76104
Country
United States
Facility Name
Benchmark Research
City
Fort Worth
State/Province
Texas
ZIP/Postal Code
76135
Country
United States
Facility Name
DM Clinical Research
City
Houston
State/Province
Texas
ZIP/Postal Code
77065
Country
United States
Facility Name
DM Clinical Research
City
Houston
State/Province
Texas
ZIP/Postal Code
77081
Country
United States
Facility Name
Ventavia Research Group
City
Keller
State/Province
Texas
ZIP/Postal Code
76248
Country
United States
Facility Name
DELRICHT RESEARCH at ZOMNIR FAMILY MEDICINE
City
McKinney
State/Province
Texas
ZIP/Postal Code
75072
Country
United States
Facility Name
Research Your Health
City
Plano
State/Province
Texas
ZIP/Postal Code
75093
Country
United States
Facility Name
Be Well Clinical Studies
City
Round Rock
State/Province
Texas
ZIP/Postal Code
78681
Country
United States
Facility Name
Clinical Trials of Texas, Inc.
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Diagnostics Research Group
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78229
Country
United States
Facility Name
Tekton Research -San Antonio
City
San Antonio
State/Province
Texas
ZIP/Postal Code
78240
Country
United States
Facility Name
DM Clinical Research
City
Sugar Land
State/Province
Texas
ZIP/Postal Code
77478
Country
United States
Facility Name
DM Clinical Research
City
Tomball
State/Province
Texas
ZIP/Postal Code
77375
Country
United States
Facility Name
Cope Family Medicine
City
Bountiful
State/Province
Utah
ZIP/Postal Code
84010
Country
United States
Facility Name
Mountain View Ogden Clinic/CCT Research
City
Pleasant View
State/Province
Utah
ZIP/Postal Code
84404
Country
United States
Facility Name
JBR Clinical Research
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84107
Country
United States
Facility Name
J. Lewis Research, Inc. / Foothill Family Clinic South
City
Salt Lake City
State/Province
Utah
ZIP/Postal Code
84121
Country
United States
Facility Name
Health Research of Hampton Roads, Inc.
City
Newport News
State/Province
Virginia
ZIP/Postal Code
23606
Country
United States
Facility Name
Velocity Clinical Research
City
Portsmouth
State/Province
Virginia
ZIP/Postal Code
23703
Country
United States
Facility Name
Clinical Research Partners, LLC
City
Richmond
State/Province
Virginia
ZIP/Postal Code
23226
Country
United States
Facility Name
Hamilton Medical Research group
City
Hamilton
State/Province
Ontario
ZIP/Postal Code
L8M 1K7
Country
Canada
Facility Name
Milestone Research Inc.
City
London
State/Province
Ontario
ZIP/Postal Code
N5W 6A2
Country
Canada
Facility Name
Red Maple Trials Inc.
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1H1E4
Country
Canada
Facility Name
Winterberry Family Medicine
City
Stoney Creek
State/Province
Ontario
ZIP/Postal Code
L8J0B6
Country
Canada
Facility Name
Medicor Research Inc.
City
Sudbury
State/Province
Ontario
ZIP/Postal Code
P3C 1X3
Country
Canada
Facility Name
Dr. Anil K. Gupta Medicine Professional Corporation
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M9V 4B4
Country
Canada
Facility Name
Centricity Research Toronto Manna Multispecialty
City
Toronto
State/Province
Ontario
ZIP/Postal Code
M9W 4L6
Country
Canada
Facility Name
Intermed groupe santé
City
Chicoutimi
State/Province
Quebec
ZIP/Postal Code
G7H 7Y8
Country
Canada
Facility Name
Centricity Research Pointe-Claire
City
Pointe-Claire
State/Province
Quebec
ZIP/Postal Code
H9R 4S3
Country
Canada
Facility Name
Manna Research Inc.
City
Pointe-Claire
State/Province
Quebec
ZIP/Postal Code
H9R 4S3
Country
Canada
Facility Name
Q&T Research Sherbrooke Inc.
City
Sherbrooke
State/Province
Quebec
ZIP/Postal Code
J1J 2G2
Country
Canada
Facility Name
Clinique spécialisée en allergie
City
Quebec
ZIP/Postal Code
G1V 4W2
Country
Canada
Facility Name
Barnsley Hospital
City
Barnsley
Country
United Kingdom
Facility Name
Royal United Hospital Bath NHS Trust - Royal United Hospital
City
Bath
Country
United Kingdom
Facility Name
Layton Medical Centre
City
Blackpool
Country
United Kingdom
Facility Name
Dorset Clinical Research Centre (Bournemouth Hospital)
City
Bournemouth
Country
United Kingdom
Facility Name
Bradford Teaching Hospitals NHS Foundation Trust - Bradford
City
Bradford
Country
United Kingdom
Facility Name
Lakeside Healthcare
City
Corby
Country
United Kingdom
Facility Name
Rotherham Doncaster and South Humber NHS Foundation Trust
City
Doncaster
Country
United Kingdom
Facility Name
University of Dundee - NHS Tayside - Ninewells Hospital & Me
City
Dundee
Country
United Kingdom
Facility Name
Western General Hospital
City
Edinburgh
Country
United Kingdom
Facility Name
Royal Devon & Exeter Hospital
City
Exeter
Country
United Kingdom
Facility Name
CPS Research
City
Glasgow
Country
United Kingdom
Facility Name
NHS Greater Glasgow & Clyde
City
Glasgow
Country
United Kingdom
Facility Name
Panthera Biopartners - Glasgow - multispeciality
City
Glasgow
Country
United Kingdom
Facility Name
Queen Elizabeth University Hospital
City
Glasgow
Country
United Kingdom
Facility Name
Gloucestershire Hospitals NHS Foundation Trust - Cheltenham
City
Gloucester
Country
United Kingdom
Facility Name
Velocity Clinical Research High Wycombe
City
High Wycombe
Country
United Kingdom
Facility Name
University Hospitals of Leicester-Leicester Royal Hospital
City
Leicester
Country
United Kingdom
Facility Name
Barts Health NHS Trust
City
London
Country
United Kingdom
Facility Name
Egin Research
City
London
Country
United Kingdom
Facility Name
Guys and St. Thomas NHS Foundation Trust
City
London
Country
United Kingdom
Facility Name
Hammersmith Medicines Research (HMR)
City
London
Country
United Kingdom
Facility Name
Panthera Biopartners - Enfield
City
London
Country
United Kingdom
Facility Name
Richford Gate Medical Practice
City
London
Country
United Kingdom
Facility Name
Royal Free London NHS Foundation Trust
City
London
Country
United Kingdom
Facility Name
St Georges Healthcare NHS Trust - University of London
City
London
Country
United Kingdom
Facility Name
Manchester University NHS Foundation Trust
City
Manchester
Country
United Kingdom
Facility Name
Bioluminux Clinical Research
City
Milton Keynes
Country
United Kingdom
Facility Name
Newcastle University - Institute of Cellular Medicine (ICM)
City
Newcastle
Country
United Kingdom
Facility Name
Velocity Clinical Research
City
North London
Country
United Kingdom
Facility Name
Accellacare North London
City
Northwood
Country
United Kingdom
Facility Name
Nottingham University Hospitals NHS Trust - Queens Medical Centre (QMC) Campus
City
Nottingham
Country
United Kingdom
Facility Name
Stemax Consult Healthcare Services Ltd
City
Old Stratford
Country
United Kingdom
Facility Name
Wansford and Kings Cliffe Practice
City
Peterborough
Country
United Kingdom
Facility Name
University Hospitals Plymouth NHS Trust
City
Plymouth
Country
United Kingdom
Facility Name
Southampton General Hospital - Portsmouth Research Hub
City
Portsmouth
Country
United Kingdom
Facility Name
GST NHS Found
City
Preston
Country
United Kingdom
Facility Name
Panthera Biopartners Preston
City
Preston
Country
United Kingdom
Facility Name
Panthera Biopartners - Manchester - multispeciality
City
Rochdale
Country
United Kingdom
Facility Name
Warrington and Halton Teaching hospitals NHS Foundation Trust - Halton General Hospital
City
Runcorn
Country
United Kingdom
Facility Name
Panthera Biopartners - Sheffield - multispeciality
City
Sheffield
Country
United Kingdom
Facility Name
Royal Victoria Infirmary
City
Sheffield
Country
United Kingdom
Facility Name
Southampton University Hospital NHS Foundation Trust
City
Southampton
Country
United Kingdom
Facility Name
Pier Health Group
City
Weston-super-Mare
Country
United Kingdom
Facility Name
Weymouth Research Hub
City
Weymouth
Country
United Kingdom
Facility Name
North Wales Clinical Research Centre
City
Wrexham
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ≥12 Years of Age to Prevent COVID-19

We'll reach out to this number within 24 hrs